Tetrabenazine Tablet
Product Images NDC 68094-905

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 68094-905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Bottle Label (Export 00)

Tetrabenazine 25 mg tablets packaging label showing 112 tablets in the bottle. The label includes the drug name, strength, a barcode, and manufacturer information for Precision Dose Inc. It also provides storage and usage instructions, and a note that a medication guide is dispensed with each prescription.*

FDA Label Image

12.5 mg Bottle Label (Export 01)

Label for Tetrabenazine Tablets 12.5 mg by Precision Dose Inc. The label indicates it is an oral tablet prescription drug with 112 tablets in the package. It includes dosage and storage instructions, a barcode, and a medication guide notice.*

FDA Label Image

Figure 2 (Export 02)

A cumulative percentage of patients chart displaying change from baseline in chorea score, comparing Tetrabenazine and Placebo treatment groups. The graph shows cumulative percentage on the vertical axis and change from baseline in chorea score on the horizontal axis, with annotations marking 3, 6, and 10 points improvement. A table inset shows percentages of patients achieving specific reductions (-10, -6, -3) in total chorea score for both groups.*

FDA Label Image

Figure 1 (Export 03)

A line graph showing chorea score changes over study weeks comparing Tetrabenazine and placebo. The x-axis represents study weeks from -1 to 14; the y-axis shows chorea score change from 1 to -7. The graph includes error bars and indicates a washout period around week 12. Tetrabenazine shows a larger decrease in chorea score than placebo during treatment weeks.*

FDA Label Image

Tetrabenazine Structural Formula (Export 04)

Chemical structure of tetrabenazine, showing the molecular arrangement of atoms including methoxy groups and a ketone group in a cyclic amine framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.